All Stories

  1. Clinical reasoning in pharmacy: What do eye movements and verbal protocols tell us about the processing of a case task?
  2. Unleashing the Potential of Medicinal Plants in Benin: Assessing the Status of Research and the Need for Enhanced Practices
  3. Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria
  4. Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans
  5. A proteomics study on how Chlamydia pneumoniae affects macrophages
  6. The influence of dibenzocyclooctadiene lignans on macrophage glutathione and lipid metabolism associated with Chlamydia pneumoniae-induced foam cell formation
  7. University students' study progress
  8. Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
  9. a model to study C. pneumoniae infection
  10. Growth Mode and Physiological State of Cells Prior to Biofilm Formation Affect Immune Evasion and Persistence of Staphylococcus aureus
  11. Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers
  12. Assaying Chlamydia pneumoniae persistence in monocyte-derived macrophages identifies schisandrin lignans as phenotypic switchers
  13. Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells
  14. Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy
  15. Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
  16. Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors
  17. Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae
  18. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
  19. Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis
  20. Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation
  21. How to Translate a Bioassay Into a Screening Assay for Natural Products: General Considerations and Implementation of Antimicrobial Screens
  22. Recent advances in technologies for developing drugs againstChlamydia pneumoniae
  23. Tailored beads made of dissolved cellulose—Investigation of their drug release properties
  24. Commercial peppermint (Mentha×piperita L.) teas: Antichlamydial effect and polyphenolic composition
  25. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques
  26. Aggregating Behavior of Phenolic Compounds — A Source of False Bioassay Results?
  27. Ent-kauren-19-oic acid derivatives from the stem bark of Croton pseudopulchellus Pax
  28. Conformation study of 2-arylbenzimidazoles as inhibitors of Chlamydia pneumoniae growth
  29. Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
  30. Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro
  31. Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae
  32. The Binding of Synthetic Retinoids to Lipocalin β-Lactoglobulins
  33. Betulin-Derived Compounds as Inhibitors of Alphavirus Replication
  34. A luciferase-based screening method for inhibitors of alphavirus replication applied to nucleoside analogues
  35. Comparison of transgenic Gerbera hybrida lines and traditional varieties shows no differences in cytotoxicity or metabolic fingerprints
  36. Predictive value of cellular methods in toxicological evaluation of lead candidates: an insight to hepatotoxicity
  37. Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays